Ethanol metabolism alters major histocompatibility complex class I–restricted antigen presentation in liver cells

Authors

  • Natalia A. Osna,

    Corresponding author
    1. Liver Study Unit, Omaha Veterans Affairs (VA) Medical Center, Omaha, NE
    2. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
    • Liver Study Unit, Research Service (151), VA Medical Center, 4101 Woolworth Avenue, Omaha, NE 68105
    Search for more papers by this author
    • fax: 402-449-0604.

  • Ronda L. White,

    1. Liver Study Unit, Omaha Veterans Affairs (VA) Medical Center, Omaha, NE
    2. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
    Search for more papers by this author
  • Geoffrey M. Thiele,

    1. Liver Study Unit, Omaha Veterans Affairs (VA) Medical Center, Omaha, NE
    2. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
    Search for more papers by this author
  • Terrence M. Donohue Jr.

    1. Liver Study Unit, Omaha Veterans Affairs (VA) Medical Center, Omaha, NE
    2. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

Abstract

The proteasome is a major enzyme that cleaves proteins for antigen presentation. Cleaved peptides traffic to the cell surface, where they are presented in the context of major histocompatibility complex (MHC) class I. Recognition of these complexes by cytotoxic T lymphocytes is crucial for elimination of cells bearing “nonself” proteins. Our previous studies revealed that ethanol suppresses proteasome function in ethanol-metabolizing liver cells. We hypothesized that proteasome suppression reduces the hydrolysis of antigenic peptides, thereby decreasing the presentation of the peptide MHC class I complexes on the cell surface. To test this we used the mouse hepatocyte cell line (CYP2E1/ADH-transfected HepB5 cells) or primary mouse hepatocytes, both derived from livers of C57Bl/6 mice, which present the ovalbumin peptide, SIINFEKL, complexed with H2Kb. To induce H2Kb expression, HepB5 cells were treated with interferon gamma (IFNγ) and then exposed to ethanol. In these cells, ethanol metabolism decreased not only proteasome activity, but also hydrolysis of the C-extended peptide, SIINFEKL-TE, and the presentation of SIINFEKL-H2Kb complexes measured after the delivery of SIINFEKL-TE to cytoplasm. The suppressive effects of ethanol were, in part, attributed to ethanol-elicited impairment of IFNγ signaling. However, in primary hepatocytes, even in the absence of IFNγ, we observed a similar decline in proteasome activity and antigen presentation after ethanol exposure. Conclusion: Proteasome function is directly suppressed by ethanol metabolism and indirectly by preventing the activating effects of IFNγ. Ethanol-elicited reduction in proteasome activity contributes to the suppression of SIINFEKL-H2Kb presentation on the surface of liver cells. (HEPATOLOGY 2009.)

Ancillary